An off-the-shelf vascular graft biomaterial for vascular bypass surgeries is an unmet clinical need. The vascular biomaterial must support cell growth, be non-thrombogenic, minimize intimal hyperplasia, match the structural properties of native vessels, and allow for regeneration of arterial tissue. Electrospun recombinant human tropoelastin (rTE) as a medial component of a vascular graft scaffold was investigated in this study by evaluating its structural properties, as well as its ability to support primary smooth muscle cell adhesion and growth. rTE solutions of 9, 15, and 20 wt% were electrospun into sheets with average fiber diameters of 167 ± 32, 522 ± 67, and 735 ± 270 nm, and average pore sizes of 0.4 ± 0.1, 5.8 ± 4.3, and 4.9 ± 2.4 µm, respectively. Electrospun rTE fibers were cross-linked with disuccinimidyl suberate to produce an insoluble fibrous polymeric recombinant tropoelastin (prTE) biomaterial. Smooth muscle cells attached via integrin binding to the rTE coatings and proliferated on prTE biomaterials at a comparable rate to growth on prTE coated glass, glass alone, and tissue culture plastic. Electrospun tropoelastin demonstrated the cell compatibility and design flexibility required of a graft biomaterial for vascular applications.
Lloyd-JonesDAdamsRJBrownTMCarnethonMDaiSDe SimoneG. Heart disease and stroke statistics–2010 update: a report from the American Heart Association. Circulation2009; 121: e46–e215.
AbbottWMRehringTF. Biologic and synthetic prosthetic materials for vascular conduits. In: HobsonRWWilsonSVeithFJ (eds) Vascular surgery: principles and practice, 3rd ed. New York: Marcel Dekker, 2004, pp. 611–620.
4.
SawyerPNFitzgeraldJKaplittMJSandersRJWilliamsGMLeatherRP. Ten year experience with the negatively charged glutaraldehyde-tanned vascular graft in peripheral vascular surgery. Initial multicenter trial. Am J Surg1987; 154: 533–537.
5.
DardikHWengerterKQinFPangilinanASilvestriFWolodigerF. Comparative decades of experience with glutaraldehyde-tanned human umbilical cord vein graft for lower limb revascularization: an analysis of 1275 cases. J Vasc Surg2002; 35: 64–71.
6.
StrobelRBoontjeAHVan Den DungenJJ. Aneurysm formation in modified human umbilical vein grafts. Eur J Vasc Endovasc Surg1996; 11: 417–420.
7.
GuiLMutoAChanSABreuerCKNiklasonLE. Development of decellularized human umbilical arteries as small-diameter vascular grafts. Tissue Eng Part A2009; 15: 2665–2676.
8.
L'HeureuxNDusserreNMariniAGarridoSde la FuenteLMcAllisterT. Technology insight: the evolution of tissue-engineered vascular grafts–from research to clinical practice. Nat Clin Pract Cardiovasc Med2007; 4: 389–395.
9.
McAllisterTNMaruszewskiMGarridoSAWystrychowskiWDusserreNMariniA. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet2009; 373: 1440–1446.
10.
MegelskiSStephensJSChaseDBRaboltJF. Micro and nano-structured surface morphology on electrospun polymer fibers. Macromolecules2002; 35: 8456–8466.
11.
MuruganRRamakrishnaS. Nano-featured scaffolds for tissue engineering: a review of spinning methodologies. Tissue Eng2006; 12: 435–447.
12.
BolandEDMatthewsJAPawlowskiKJSimpsonDGWnekGEBowlinGL. Electrospinning collagen and elastin: preliminary vascular tissue engineering. Front Biosci2004; 9: 1422–1432.
13.
RoachMRBurtonAC. The reason for the shape of the distensibility curves of arteries. Can J Biochem Physiol1957; 35: 681–690.
14.
BaxterBTMcGeeGSShivelyVPDrummondIADixitSNYamauchiM. Elastin content, cross-links, and mRNA in normal and aneurysmal human aorta. J Vasc Surg1992; 16: 192–200.
15.
CurranMEAtkinsonDLEwartAKMorrisCALeppertMFKeatingMT. The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis. Cell1993; 73: 159–168.
16.
EwartAKJinWAtkinsonDMorrisCAKeatingMT. Supravalvular aortic stenosis associated with a deletion disrupting the elastin gene. J Clin Invest1994; 93: 1071–1077.
17.
GandhiRHIrizarryECantorJOKellerSNackmanGBHalpernVJ. Analysis of elastin cross-linking and the connective tissue matrix of abdominal aortic aneurysms. Surgery1994; 115: 617–620.
18.
LiDYTolandAEBoakBBAtkinsonDLEnsingGJMorrisCA. Elastin point mutations cause an obstructive vascular disease, supravalvular aortic stenosis. Hum Mol Genet1997; 6: 1021–1028.
19.
RizzoRJMcCarthyWJDixitSNLillyMPShivelyVPFlinnWR. Collagen types and matrix protein content in human abdominal aortic aneurysms. J Vasc Surg1989; 10: 365–373.
20.
UrbanZMichelsVVThibodeauSNDonis-KellerHCsiszarKBoydCD. Supravalvular aortic stenosis: a splice site mutation within the elastin gene results in reduced expression of two aberrantly spliced transcripts. Hum Genet1999; 104: 135–142.
21.
DaamenWFVeerkampJHvan HestJCvan KuppeveltTH. Elastin as a biomaterial for tissue engineering. Biomaterials2007; 28: 4378–4398.
22.
PatelAFineBSandigMMequanintK. Elastin biosynthesis: The missing link in tissue-engineered blood vessels. Cardiovasc Res2006; 71: 40–49.
23.
ButtafocoLKolkmanNGPootAADijkstraPJVermesIFeijenJ. Electrospinning collagen and elastin for tissue engineering small diameter blood vessels. J Control Release2005; 101: 322–324.
24.
ButtafocoLKolkmanNGEngbers-BuijtenhuijsPPootAADijkstraPJVermesI. Electrospinning of collagen and elastin for tissue engineering applications. Biomaterials2006; 27: 724–734.
25.
LeeSJYooJJLimGJAtalaAStitzelJ. In vitro evaluation of electrospun nanofiber scaffolds for vascular graft application. J Biomed Mater Res A2007; 83: 999–1008.
26.
LiMMondrinosMJChenXGandhiMRKoFKLelkesPI. Co-electrospun poly(lactide-co-glycolide), gelatin, and elastin blends for tissue engineering scaffolds. J Biomed Mater Res A2006; 79: 963–973.
27.
LiMMondrinosMJGandhiMRKoFKWeissASLelkesPI. Electrospun protein fibers as matrices for tissue engineering. Biomaterials2005; 26: 5999–6008.
28.
StitzelJLiuJLeeSJKomuraMBerryJSokerS. Controlled fabrication of a biological vascular substitute. Biomaterials2006; 27: 1088–1094.
29.
RnjakJLiZMaitzPKWiseSGWeissAS. Primary human dermal fibroblast interactions with open weave three-dimensional scaffolds prepared from synthetic human elastin. Biomaterials2009; 30: 6469–6477.
30.
LowryOGilliganDKaterskyE. The determination of collagen and elastin in tissues, with results obtained in various normal tissues from different species. J Biol Chem1941; 139: 795–804.
31.
LansingARosenthalTAlexMDempseyE. The structure and chemical characterization of elastic fibers as revealed by elastase and by electron microscopy. Anat Rec1952; 114: 555–575.
32.
VartanianKBKirkpatrickSJHansonSRHindsMT. Endothelial cell cytoskeletal alignment independent of fluid shear stress on micropatterned surfaces. Biochem Biophys Res Commun2008; 371: 787–792.
33.
StegemannJPNeremRM. Phenotype modulation in vascular tissue engineering using biochemical and mechanical stimulation. Ann Biomed Eng2003; 31: 391–402.
SmithMJMcClureMJSellSABarnesCPWalpothBHSimpsonDG. Suture-reinforced electrospun polydioxanone-elastin small-diameter tubes for use in vascular tissue engineering: a feasibility study. Acta Biomater2008; 4: 58–66.
36.
SmithMJWhiteKLJrSmithDCBowlinGL. In vitro evaluations of innate and acquired immune responses to electrospun polydioxanone-elastin blends. Biomaterials2009; 30: 149–159.
37.
ThomasVZhangXCatledgeSAVohraYK. Functionally graded electrospun scaffolds with tunable mechanical properties for vascular tissue regeneration. Biomed Mater2007; 2: 224–232.
38.
ZhangXThomasVXuYBellisSLVohraYK. An in vitro regenerated functional human endothelium on a nanofibrous electrospun scaffold. Biomaterials2010; 31: 4376–4381.
39.
KoombhongseSLiuWRenekerDH. Flat polymer ribbons and other shapes by electrospinning. J Polym Sci Pol Phys2001; 39: 2598–2606.
40.
ZeugolisDIPaulGRAttenburrowG. Cross-linking of extruded collagen fibers–a biomimetic three-dimensional scaffold for tissue engineering applications. J Biomed Mater Res A2009; 89: 895–908.
41.
MithieuxSMRaskoJEWeissAS. Synthetic elastin hydrogels derived from massive elastic assemblies of self-organized human protein monomers. Biomaterials2004; 25: 4921–4927.
42.
MithieuxSMWiseSGRafteryMJStarcherBWeissAS. A model two-component system for studying the architecture of elastin assembly in vitro. J Struct Biol2005; 149: 282–289.
43.
WiseSGMithieuxSMRafteryMJWeissAS. Specificity in the coacervation of tropoelastin: solvent exposed lysines. J Struct Biol2005; 149: 273–281.
44.
Nivison-SmithLRnjakJWeissAS. Synthetic human elastin microfibers: stable cross-linked tropoelastin and cell interactive constructs for tissue engineering applications. Acta Biomater2010; 6: 354–359.
45.
DyksterhuisLBBaldockCLammieDWessTJWeissAS. Domains 17-27 of tropoelastin contain key regions of contact for coacervation and contain an unusual turn-containing crosslinking domain. Matrix Biol2007; 26: 125–135.
46.
KarnikSKBrookeBSBayes-GenisASorensenLWytheJDSchwartzRS. A critical role for elastin signaling in vascular morphogenesis and disease. Development2003; 130: 411–423.
47.
KarnikSKWytheJDSorensenLBrookeBSUrnessLDLiDY. Elastin induces myofibrillogenesis via a specific domain, VGVAPG. Matrix Biol2003; 22: 409–425.
48.
HinekAWrennDSMechamRPBarondesSH. The elastin receptor: a galactoside-binding protein. Science1988; 239: 1539–1541.
49.
HinekARabinovitchMKeeleyFOkamura-OhoYCallahanJ. The 67-kD elastin/laminin-binding protein is related to an enzymatically inactive, alternatively spliced form of beta-galactosidase. J Clin Invest1993; 91: 1198–1205.
50.
MechamRPHinekAEntwistleRWrennDSGriffinGLSeniorRM. Elastin binds to a multifunctional 67-kilodalton peripheral membrane protein. Biochemistry1989; 28: 3716–3722.
51.
RobertLJacobMPFulopTTimarJHornebeckW. Elastonectin and the elastin receptor. Pathol Biol (Paris)1989; 37: 736–741.
52.
BloodCHSasseJBrodtPZetterBR. Identification of a tumor cell receptor for VGVAPG, an elastin-derived chemotactic peptide. J Cell Biol1988; 107: 1987–1993.
53.
BroekelmannTJKozelBAIshibashiHWerneckCCKeeleyFWZhangL. Tropoelastin interacts with cell-surface glycosaminoglycans via its COOH-terminal domain. J Biol Chem2005; 280: 40939–40947.
54.
BaxDVRodgersURBilekMMWeissAS. Cell adhesion to tropoelastin is mediated via the C-terminal GRKRK motif and integrin alphaVbeta3. J Biol Chem2009; 284: 28616–28623.
